Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Blue Cell Therapeutics ApS
APS
Active
Advertising protection
CVR 39981610
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
11 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Blue Cell Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-3M
2020
-1M
2021
1M
2022
-1M
2023
-3M
2024
EBITDA
DKK millions
0M
-6M
-11M
-17M
-23M
-15M
2020
-15M
0%
2021
-15M
0%
2022
-18M
-20%
2023
-17M
+6%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-2.944
-844
852
-742
-3.053
Staff expenses
-12.007
-8.474
-11.643
-14.196
-12.786
EBITDA
-14.951
-15.163
-14.527
-17.924
-17.378
Depreciation & amort.
-0
-219
-274
-335
-163
EBIT
-14.951
-15.382
-14.800
-18.259
-17.541
Net financials
-41
-51
-64
-4
-10
Profit before tax
-14.992
-15.433
-14.865
-18.262
-17.551
Tax
-965
-1.192
-2.295
-2.974
-2.361
Net profit
-14.027
-14.241
-12.570
-15.288
-15.190
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
13.504
14.005
10.625
10.159
14.124
Equity
9.776
12.481
9.911
8.419
13.094
Long-term debt
0
0
0
0
0
Short-term debt
3.728
1.524
713
1.740
1.030
Total debt
3.728
1.524
713
1.740
1.030
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1737789400.0%
This company
2020
2024
Equity ratio
92.7%
This company
38.2%
Market median
+143% vs market
2020
2024
Return on equity
-116.0%
This company
18.4%
Market median
-730% vs market
2020
2024
Net profit margin (of gross profit)
-1518985000.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.22×
This company
2020
2024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Blue Cell Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
